Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
about
Azathioprine for multiple sclerosisIncidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisIncreased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurineLymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersReview article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseMeta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.Evidence for oligoclonal B cell expansion in the peripheral blood of patients with rheumatoid arthritis.Sjögren's syndrome and fibrosing alveolitis complicated by pulmonary lymphomaAlkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease.Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up studyMortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients.Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosisManagement of high-risk cutaneous squamous cell carcinoma.Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment.De novo malignancies after liver transplantation: a major cause of late death.Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine.Risk of cancer among rheumatoid arthritis patients in California.Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is lowStudy of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate.Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.Risk of lymphoma in patients with RA treated with anti-TNFalpha agents.Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.Azathioprine in inflammatory bowel disease, a safe alternative?Medication Exposures and Subsequent Development of Ewing Sarcoma: A Review of FDA Adverse Event Reports.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma.Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.Immunotherapy for multiple sclerosis.Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?Emerging treatments in multiple sclerosis: azathioprine and mofetil.Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?Risk of nonmelanoma skin cancer with azathioprine use.Azathioprine in inflammatory bowel disease: improved molecular insights and resulting clinical implications.Case of lung carcinoma revealed by vulvar metastasis associated with systemic scleroderma and literature review.Glucocorticoid therapy and risk of bladder cancerEfficacy and safety of drugs for ulcerative colitis.Lymphoma in inflammatory bowel disease and treatment decisions.
P2860
Q24242945-A5B9AE2F-E6C5-4C79-AD72-D044A60D6391Q24675306-706211AF-9DB3-43F4-A3B0-C5AEDA21B2FBQ24685403-58CA1E1F-52CE-4210-A698-8F7AFB3082C2Q26776151-A27D566C-24E4-4265-8297-D0A0FA764EFCQ26822029-9AECCAD1-E860-43BB-BDF2-4CCAB9B9B2E9Q33268021-3C6F9542-01D2-4672-8FEC-0B20A9CDB703Q33492638-DCD8EADA-7134-4E75-B32D-B97B6E635F0BQ33557102-94E17E5F-991E-4C28-BACC-7979F052ED25Q33557756-6673BF69-6A5E-43F6-8856-C948EB0F6173Q33560407-577D1B9E-5680-4492-BB86-4C36F38D33DCQ33561291-1A4660BF-E7D9-49B4-8440-DFC3791AB84CQ33562682-BF985F93-A819-465F-A160-77DB9EFD8CD2Q33706849-F5CA7E85-D0F4-4079-898E-65477C75B88AQ33813890-35EC0B75-A1C2-49EA-8872-DCB16F9433B7Q34066181-CDE6188A-BBAC-4430-AA78-1DB56F11C847Q34319316-3F2A6F85-4514-428B-B8A6-8A42572071D6Q34426430-67AF8094-444B-497E-8538-FBA690036FBBQ34458932-B0517891-97A8-4CF7-B508-86C16878C264Q34764697-ED8A9B7B-A995-4350-88B9-0B1682C694BBQ35162890-4AF7FAD5-392E-4833-9F30-0726AD328096Q35361609-E3D03C0C-A118-4A1C-9A1E-919745AA65F3Q35547060-7B506031-7859-4F53-8CE8-AB56FD4B2407Q35555044-AAF362EB-3CDA-456C-8D3C-BF21E5CF7744Q35555473-5F8DCF34-2BE8-4C40-A3F8-0719B5BDF4A7Q35555527-3074622F-9780-4CB9-8506-CD013FA4F842Q35609845-F117937D-DB19-400D-A23B-9BE26B5E8F56Q35630645-B3AC2CDB-916A-4462-9277-224954EE9997Q36222741-5A171995-BAE2-447C-8CB4-FFA8DBCD5219Q36431490-E2CADC3A-C623-409E-A92D-DFF35FC540EAQ36647851-C07786A2-9D1B-48FF-ADD9-FF2F25D071D8Q36850073-1DBA36AD-0D1E-437A-A619-DC064468359BQ36864836-74529D13-1C49-4B8A-8F23-08702149E528Q36887923-ACD350CA-A776-4E60-9C96-8A04D9232381Q36964382-CCF6F11E-DD36-4703-BCA6-442F6D5F0B0FQ37126243-29A30120-091B-4157-B54F-EE4632496074Q37345896-315820C0-CA17-4E52-9497-6735078E4887Q37392076-FCC3ADD4-72D3-447C-BAF3-39E2FCD20526Q37401519-D9CE4927-5D75-41B1-9A40-969AD7A0B6CDQ37727232-12095D86-CE99-4B23-828A-016A3C505C5DQ38024070-7A125E31-5AFE-4D2C-A182-DE82B75C859B
P2860
Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@en
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@nl
type
label
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@en
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@nl
prefLabel
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@en
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@nl
P1476
Incidence of cancer in rheumat ...... r immunosuppressive treatment.
@en
P2093
L J Kinlen
P356
10.1016/0002-9343(85)90245-1
P407
P577
1985-01-01T00:00:00Z